Transcriptional consequences of autosomal trisomy: Primary gene dosage with complex downstream effects

Trends in Genetics

Volumn 21, Issue 5, 2005, Pages 249-253

  FitzPatrick, David R ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; GENE PRODUCT; TRANSCRIPTOME;

ANEUPLOIDY; AUTOSOMAL DISORDER; CHROMOSOME 21; DISOMY; DOWN SYNDROME; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CHROMOSOME; MODEL; NONHUMAN; PHENOTYPE; PLOIDY; PREDICTION; PRIORITY JOURNAL; REVIEW; TRANSCRIPTOMICS; TRISOMY;

EID: 17644421353     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2005.02.012     Document Type: Short Survey

References (23)

1. C.J. Epstein The Consequences of Chromosomal Imbalance: Principals, Mechanisms, and Models 1986 Cambridge University Press
2. M.B. Petersen, and M. Mikkelsen Nondisjunction in trisomy 21: origin and mechanisms Cytogenet. Cell Genet. 91 2000 199 203
3. K. Gardiner Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions Gene 318 2003 137 147
4. R.H. Reeves A mouse model for Down syndrome exhibits learning and behaviour deficits Nat. Genet. 11 1995 177 184
5. H. Sago Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities Proc. Natl. Acad. Sci. U. S. A. 95 1998 6256 6261
6. J.T. Richtsmeier Craniofacial phenotypes in segmentally trisomic mouse models for Down syndrome Am. J. Med. Genet. 107 2002 317 324
7. D.R. FitzPatrick Transcriptome analysis of human autosomal trisomy Hum. Mol. Genet. 11 2002 3249 3256
8. R. Mao Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain Genomics 81 2003 457 467
9. K. Amano Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome Hum. Mol. Genet. 13 2004 1333 1340
10. P. Kahlem Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of Down syndrome Genome Res. 14 2004 1258 1267
11. R. Lyle Gene expression from the aneuploid chromosome in a trisomy mouse model of Down syndrome Genome Res. 14 2004 1268 1274
12. N.G. Saran Global disruption of the cerebellar transcriptome in a Down syndrome mouse model Hum. Mol. Genet. 12 2003 2013 2019
13. S.E. Antonarakis Chromosome 21 and down syndrome: from genomics to pathophysiology Nat. Rev. Genet. 5 2004 725 738
14. J.A. Birchler Dosage-dependent gene regulation in multicellular eukaryotes: implications for dosage compensation, aneuploid syndromes, and quantitative traits Dev. Biol. 234 2001 275 288
15. L. Dauphinot The cerebellar transcriptome during postnatal development of the Ts1Cje mouse, a segmental trisomy model for Down syndrome Hum. Mol. Genet. 14 2005 373 384
16. A. Daniel Karyotype, phenotype and parental origin in 19 cases of triploidy Prenat. Diagn. 21 2001 1034 1048
17. G.S. Eakin, and R.R. Behringer Tetraploid development in the mouse Dev. Dyn. 228 2003 751 766
18. T. Hassold A cytogenetic study of 1000 spontaneous abortions Ann. Hum. Genet. 44 1980 151 178
19. A.K. Hackshaw, and N.J. Wald Revised distribution parameters for serum markers for trisomy 18 J. Med. Screen. 7 2000 215
20. D.A. Aitken First-trimester biochemical screening for fetal chromosome abnormalities and neural tube defects Prenat. Diagn. 13 1993 681 689
21. P.A. Gray Mouse brain organization revealed through direct genome-scale TF expression analysis Science 306 2004 2255 2257
22. L.L. Baxter Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse Hum. Mol. Genet. 9 2000 195 202
23. M. Guo Dosage effects on gene expression in a maize ploidy series Genetics 142 1996 1349 1355